Twaron

You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.

Jump to: navigation, search

Twaron is the brandname of Teijin Aramid for a para-aramid.

Contents

History

Twaron is a heat-resistant and strong synthetic fiber developed in the early 1970s by the Dutch company AKZO, division Enka, later Akzo Industrial Fibers. The research name of the para-aramid fiber was originally Fiber X, but it was soon called Arenka. Although the dutch para-aramid fiber was developed only little later than DuPont's Kevlar, its introduction was much later due to financial problems at the AKZO company in the 1970s. A short overview of the history of Twaron[1]:

  • In 1960s start of research program for Fiber X.
  • In 1972 the ENKA Research laboratory had developed a para-aramid called Arenka.
  • In 1973 Akzo decided to use sulphuric acid (H2SO4) as a solvent for spinning.
  • In 1976 a pilot plant was built. First production in 1977.
  • In 1984 the product was renamed Twaron.
  • In 1986 commercial production was started on 3 locations and 9 plants.
  • In 1987 Twaron is introduced as a commercial product.
  • In 1989 the aramid business of Akzo became an independent Business Unit called Twaron BV.
  • Since 2000 Twaron BV is owned by the Teijin Group, now called Teijin Twaron BV and based in Arnhem, The Netherlands. The main production facilities for Twaron are in Emmen en Delfzijl.
  • In 2007 Teijin Twaron is expanding for the fourth time in six years [2] and also changes its name into Teijin Aramid.

Production

Polymer preparation

Twaron is a p-phenylene terephtalamide (PpPTA), the simplest form of the AABB para polyaramide. PpPTA is a product of p-phenylene diamine (PPD) and terephtaloyl dichloride (TDC). To dissolve the aromatic polymer Twaron used a co-solvent of N-methyl pyrrolidone (NMP) and an ionic component (Calcium Chloride (CaCl2) to occupy the hydrogen bonds of the amide groups. Prior to the invention of this process by Leo Vollbracht, working at the Dutch chemical firm AKZO, no practical means of dissolving the polymer was known. The use of this system by DuPont led to a patent war between AKZO and DuPont as Dupont initially used the carcinogenic HMPT (hexamethyl fosfortriamide). Despite heavy research DuPont now also uses the AKZO patent to use the less hazardous NMP in the Kevlar process.

Spinning

After the production of the Twaron polymer in Delfzijl, the polymer is brought to Emmen, where fibers are produced by spinning the dissolved polymer into a solid fiber from a liquid chemical blend. Polymer solvent for spinning PPTA is generally 100% (water free) sulphuric acid (H2SO4). The polymer is dissolved by mixing frozen sulphuric acid in powder form with the polymer in powder form and gently heating the mixture. This process, which differs from the more difficult DuPont process, was invented by Henri Lammers and patented by AKZO.

Major industrial uses

Twaron is a para-aramid and is used in automotive, construction, sport, aerospace, military and industry applications, e.g., "bullet-proof" body armor, fabric, and as an asbestos substitute.

See also

References

  1. Year of Twaron. "Twaron - A history of innovation". Twaron News (June 2007): 10-11.
  2. International Fiber Journal (2007). "Teijin Launches Fourth Production Expansion in Six Years". Fiber Journal (February): 20.
  • JWS Hearle. High-performance fibres. Woodhead Publishing Ltd., Abington, UK - The Textile Institute. ISBN 1855735393. 
  • Doetze J. Sikkema (2002). "Manmade fibers one hundred years: Polymers and polymer design". J Appl Polym Sci, John Wiley & Sons, Inc. (83): 484-488.
  • L. Vollbracht and T.J. Veerman, US Patent 4308374 (1976)

External links


Template:TEIJINcs:Twaron de:Twaronnl:Twaron


WikiDoc Help Menu

Quick Start..

Editing basics

Advanced editing

Communicating your edits

Help Videos You Can Watch

Acknowledgement and Attribution Regarding Sources of Content

Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

related articles
viewed previously [ + ]
In other languages